Skip to content | Change text size
 

Suzanne M Caliph

photo of Suzanne M. Caliph, Senior Lecturer in Pharmaceutics

Lecturer

BPharm Monash University
MPharmSc Monash University
GCHE Monash University

Phone: +61 3 9903 9682
Fax: +61 3 9903 9583
Email: suzanne.caliph@pharm.monash.edu.au

Drug Delivery, Disposition and Dynamics, Monash Institute of Pharmaceutical Sciences

Research interests

  • Oral bioavailability enhancement of poorly water soluble and lipophilic drugs
  • Lipid-based formulation design and bioavailability assessment
  • Drug delivery to the lymphatic system
  • Drug delivery to the central nervous system

Education

  • Deputy course director, Bachelor of Pharmacy
  • Year level co-ordinator, second year Bachelor of Pharmacy
  • Unit co-ordinator, Drug Delivery I, Pharmaceutical microbiology II, Bachelor of Pharmacy

Lecturer: 

  • Solid, semi-solid and liquid pharmaceutical formulations
  • Physical and microbial stability
  • Sterile formulations and aseptic production
  • Sterilisation, disinfection and preservation

Representative publications

  1. Caliph SM, Faassen F, Vogel GM, Porter CJH. Intestinal lymphatic transport of two highly lipophilic immunomodulator analogues after administration in a lipid based formulation. In Proceedings of the Pharmaceutical Science World Congress. Publisher – International Pharmaceutical Federation. 2007; DDM 051
  2. Caliph SM, Faassen WA, Vogel GM, Porter CJH. The role of lymphatic transport in the oral bioavailability of two highly lipophilic immunomodular compounds after administration in a lipid based formulation. In Proceedings of APSA - Australasian Pharmaceutical Sciences Association. 2005;85.
  3. Jones K, Larson IC, Weaver D, Caliph SM. The adventures of Trev the tablet: Replacing practical classes and lectures using an online game scenario.Australasian Journal of Educational Technology. 2005; 309-312.
  4. Caliph SM, Charman WN, Porter CJH. Systemic exposure of a model lipophilic drug is changed when drug enters the circulation in association with lymph as opposed to plasma.Proceedings of Australasian Pharmaceutical Sciences Association. 2004; 47:104.
  5. Caliph SM,Onsman A. A Review of outsourced sterile dispensing learning activities. Proceedings of Australasian Pharmaceutical Sciences Association. 2003; 88:132.
  6. Edwards GA, Porter CJH, Caliph SM, Khoo SM, Charman WN. Animal models for the study of intestinal lymphatic drug transport.Advanced Drug Deliv Review. 2001;50(1-2):45-60.
  7. Caliph SM, Charman WN, Porter CJH. Effect of short, medium, and long-chain fatty acid based vehicles on the absolute oral bioavailability and intestinal lymphatic transport of halofantrine and assessment of mass balance in lymph-cannulated and non-cannulated rats.J Pharm Sci. 2000;89(8):1073-1084.
  8. S.M Caliph, Charman WN C.J.H Porter. The bioavailability of a highly lipophilic compound after oral administration in lipidic and lipid free formulations: Assessment in lymph fistulated and non-lymph fistulated rat models.Proceedings of Australasian Society of Clinical and Experimental Pharmacology and Toxicology and the Australasian Pharmaceutical Sciences Association. 1998; O14.4:63.
  9. Caliph SM, Charman WN, Porter CJH. The effect of medium and long chain lipids on the lymphatic transport and bioavailability of halofantrine, a highly lipophilic drug, after oral administration to conscious rats.Proceedings of Australasian Pharmaceutical Sciences Association. 1997; 19:53.
  10. Porter CJH, Caliph SM, Charman WN. Differences in pre- and post-prandial plasma lipid profiles affect the extraction efficiency of a model highly lipophilic drug from plasma.J Pharm Biomed Anal. 1997;16(1):175-180.
  11. Caliph SM, Charman WN, Porter CJH. Differences in plasma lipid profiles affect the extraction efficiency of a model highly lipophilic drug from plasma.Australian Journal of Hospital Pharmacy (Supp). 1996; 26.

External appointments

  • The Board of Examiners, Pharmacy Board of Victoria Registration Examinations